Menu Search
Equities

Imaging Biometrics Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
5Y1:MUN

Imaging Biometrics Ltd

Actions
  • Price (EUR)0.009
  • Today's Change0.00 / 0.00%
  • Shares traded4.00k
  • 1 Year change-43.75%
  • Beta2.5685
Data delayed at least 15 minutes, as of Mar 03 2026 07:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Imaging Biometrics Limited is a Jersey-based company. The Company is engaged in the provision of clinical treatments to patients in the field of medical imaging diagnostics, based on technology. The Company’s segments include Holding company, Medical Software, and Oral gallium maltolate (GaM). Its subsidiaries include Imaging Biometrics, LLC and Stone Checker Software Limited. Imaging Biometrics LLC develops ready-to-use software applications for the healthcare industry. Stone Checker Software Limited is a supplier of technology solutions in the field of kidney stone analysis and kidney stone prevention. Its Kirkstall Limited has developed Quasi Vivo an advanced interconnected cell culture flow system, engineered to provide vivo-like conditions for cell growth.

  • Revenue in GBP (TTM)699.86k
  • Net income in GBP-142.44k
  • Incorporated1965
  • Employees7.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.